FDA Inspection
AltaThera Pharmaceuticals LLCAltaThera Pharmaceuticals LLC – FDA Inspection, Jun 17, 2022
Record Details
This FDA Inspection record concerns AltaThera Pharmaceuticals LLC, with an inspection on June 17, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 17, 2022
- Product Type
- Drugs
View Company Profile
ID · 4af18337-e765-4874-97cc-2097745de443
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1172132
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 314.81(b)(2)Timely submission
- 21 CFR 314.80(c)(2)Late submission of annual safety reports
- 21 CFR 314.80(b)Failure to develop written procedures
- 21 CFR 314.80(j)Failure to maintain records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AltaThera Pharmaceuticals LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 23, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 19, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AltaThera Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.